PRODUCTION OF NOVEL NEWCASTLE DISEASE VIRUS STRAINS FROM cDNAS AND IMPROVED LIVE ATTENUATED NEWCASTLE DISEASE VACCINES
    1.
    发明申请
    PRODUCTION OF NOVEL NEWCASTLE DISEASE VIRUS STRAINS FROM cDNAS AND IMPROVED LIVE ATTENUATED NEWCASTLE DISEASE VACCINES 审中-公开
    从cDNAs和改良的活的老年病毒疫苗中产生新的新生病毒病毒菌株

    公开(公告)号:WO00067786A1

    公开(公告)日:2000-11-16

    申请号:PCT/US2000/006700

    申请日:2000-05-05

    摘要: The present invention concerns cDNAs for making attenuated, infectious Newcastle disease virus (NDV). Another aspect of the invention relates to methods of making the cDNAs. Another aspect of the invention is a vector containing the cDNA optionally linked to an operable promoter. Within the scope of the invention are vaccines comprising the attenuated, infectious NDV. Also disclosed are methods of making the vaccines and methods of using the vaccines to prevent or treat Newcastle disease in an avian host. The present invention also concerns the nucleotide sequences of the entire genome of NDV, the leading region, the trailing region, and the NP region, as well as proteins encoded by these nucleotide sequences.

    摘要翻译: 本发明涉及用于制备减毒,感染性新城疫病毒(NDV)的cDNA。 本发明的另一方面涉及制备cDNA的方法。 本发明的另一方面是含有任选地连接到可操作的启动子的cDNA的载体。 在本发明的范围内是包含减毒,感染性NDV的疫苗。 还公开了制备疫苗的方法和使用疫苗来预防或治疗禽类宿主中的新城疫病的方法。 本发明还涉及NDV,前导区域,尾区域和NP区域的全部基因组的核苷酸序列以及由这些核苷酸序列编码的蛋白质。

    ATTENUATED ONCOLYTIC PARAMYXOVIRUSES ENCODING AVIAN CYTOKINES
    2.
    发明申请
    ATTENUATED ONCOLYTIC PARAMYXOVIRUSES ENCODING AVIAN CYTOKINES 审中-公开
    编码肺炎细胞因子的衰老性光炎病毒

    公开(公告)号:WO2009095167A1

    公开(公告)日:2009-08-06

    申请号:PCT/EP2009/000308

    申请日:2009-01-20

    IPC分类号: A61K35/76

    摘要: The invention refers to a recombinant oncolytic RNA Newcastle Disease Virus for the treatment of a proliferative disease, comprising at least one transgene coding for an avian cytokine, wherein the recombinant oncolytic RNA Newcastle Disease Virus is obtainable from a velogenic or mesogenic oncolytic RNA Newcastle Disease Virus. Virus-mediated expression of the cytokine in the natural host cells leads to a reduced pathogenicity of the virus for avian species. Furthermore the virus genome can encode binding proteins, prodrug-converting enzymes or/and proteases. The selective expression of these molecules in virus-infected tumor cells increases the anti-tumor effect of the virus.

    摘要翻译: 本发明涉及用于治疗增殖性疾病的重组溶瘤性RNA新城疫病毒,其包含编码禽类细胞因子的至少一种转基因,其中所述重组溶瘤性RNA新城疫病毒可从慢性或溶媒性新城疫病毒 。 细胞因子在天然宿主细胞中的病毒介导的表达导致病毒对禽类物种的致病性降低。 此外,病毒基因组可编码结合蛋白,前药转化酶或/和蛋白酶。 这些分子在病毒感染的肿瘤细胞中的选择性表达增加了病毒的抗肿瘤作用。